Respiratory disorders pharyngitis

The following adverse events were reported in at least 3% of all patients Infection headache rhinitis nausea dizziness pharyngitis cough asthenia abdominal pain rash respiratory disorder dyspepsia sinusitis vomiting peripheral edema mouth ulcer alopecia injection site reaction. 

Adverse reactions that occurred in at least 3% of patients included the following Aggravated diabetes mellitus, edema, headache, hypoglycemia, myalgia, pharyngitis, sinusitis, tooth disorder, upper respiratory tract infection. 

Infliximab 5 or 10 mg/kg for 3 intravenous infusions at weeks 0, 2, and 6 Headaches, fever, chills, fatigue, diarrhea, pharyngitis, upper respiratory and urinary tract infections hypersensitivity reactions (urticaria, dyspnea, hypotension) lymphoproliferative disorders... 

---